Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.285 USD | -1.15% | -8.10% | +48.30% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 163M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -39M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.2
x | P/E ratio 2025 * |
-4.48
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Atossa Therapeutics, Inc.
1 day | -0.38% | ||
1 week | -10.96% | ||
1 month | -14.47% | ||
3 months | +30.00% | ||
6 months | +71.10% | ||
Current year | +47.73% |
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 1.305 | +0.38% | 312 805 |
24-05-31 | 1.3 | 0.00% | 956,025 |
24-05-30 | 1.3 | -1.52% | 727,942 |
24-05-29 | 1.32 | -7.04% | 1,459,206 |
24-05-28 | 1.42 | -2.74% | 1,220,056 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.73% | 163M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- ATOS Stock